# Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years

> **NCT00219752** · PHASE2 · COMPLETED · sponsor: **Poitiers University Hospital** · enrollment: 30 (—)

## Conditions studied

- Chronic Myeloid Leukemia

## Interventions

- **DRUG:** Imatinib mesylate 400 mg

## Key facts

- **NCT ID:** NCT00219752
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 30 (—)
- **Last updated:** 2005-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00219752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00219752, "Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00219752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*